SBT115301 + Placebo
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 19/100
19
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedAbout SBT115301 + Placebo
SBT115301 + Placebo is a phase 1 stage product being developed by Sonoma Pharmaceuticals for Safety. The current trial status is completed. This product is registered under clinical trial identifier NCT05388981. Target conditions include Safety.
What happened to similar drugs?
3 of 4 similar drugs in Safety were approved
Approved (3) Terminated (0) Active (1)
Hype Score Breakdown
Clinical
6
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05388981 | Phase 1 | Completed |
Competing Products
20 competing products in Safety